Description
OneOme DNA Sample
OneOme, co-founded by Mayo Clinic, provides evidence-based pharmacogenomic solutions that help improve patient outcomes and reduce costs through more personalized medication decisions.
Pharmacogenomic (PGx) testing analyzes a patient’s DNA and provides insights to help providers make informed prescribing decisions for that patient. The RightMed Test is a PGx test that offers comprehensive coverage backed by rigorous curation of high-level, scientific evidence to give providers and their patients confidence in test results.
The RightMed Test covers 27 genes that may impact how a patient responds to certain medications used to treat varied medical conditions.
